Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data-Reference-Cited by-同舟云学术

Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data

Published:2008-07-29 Issue:2 Volume:20 Page:291-297
ISSN:0937-941X
Container-title:Osteoporosis International
language:en
Short-container-title:Osteoporos Int

Author:

Cranney A.,Wells G. A.,Yetisir E.,Adami S.,Cooper C.,Delmas P. D.,Miller P. D.,Papapoulos S.,Reginster J.-Y.,Sambrook P. N.,Silverman S.,Siris E.,Adachi J. D.

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s00198-008-0653-8.pdf

Reference15 articles.

1. Chesnut CH III, Skag A, Christiansen C, Recker R, Stakkestad JA, Hoiseth A et al (2004) Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis. J Bone Miner Res 8:1241–1249

2. Recker R, Stakkestad JA, Chesnut CH III, Christiansen C, Skag A, Hoiseth A et al (2004) Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis. Bone 34(5):890–899

3. Miller PD, McClung MR, Macovei L, Stakkestad JA, Luckey M, Bonvoisin B et al (2005) Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study. J Bone Miner Res 20(8):1315–1322

4. Delmas PD, Adami S, Strugala C, Stakkestad JA, Reginster JY, Felsenberg D et al (2006) Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum 54(6):1838–1846

5. Ravn P, Neugebauer G, Christiansen C (2002) Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis. Bone 30(1):320–324

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies;International Journal of Clinical Pharmacy;2023-12-19

2. Ibandronate in the Prevention of Vertebral and Nonvertebral Osteoporotic Fractures;JCR: Journal of Clinical Rheumatology;2022-09-28

3. Sensitive and accurate method for chromatographic quantification of ibandronate in bulk and dosage forms;TROP J PHARM RES;2022

4. Ефективність та безпечність ібандронової кислоти: фокус на результати рандомізованих досліджень і метааналізів;PAIN, JOINTS, SPINE;2021-09-24

5. Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in China: a simulation projection model from 2020 to 2040;Archives of Osteoporosis;2021-08-02